However, of the four TFs (PITX1, RARA, FOXF1/A1, and BHLHE41/40) that matched the binding motifs in DEG promoters, only one, FOXA1, has previously been implicated in ovarian cancer specifically [83]. Here, RARA is linked to ovarian cancer.